<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03791879</url>
  </required_header>
  <id_info>
    <org_study_id>MFM IR.18.11.322 - 2018/11/11</org_study_id>
    <nct_id>NCT03791879</nct_id>
  </id_info>
  <brief_title>Caudal Dexmedetomidine Analgesia in Pediatrics .</brief_title>
  <official_title>The Analgesic Effectiveness and Safety of Upgraded Caudal Dexmedetomidine Doses in Pediatric Hypospadias Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used&#xD;
      increasingly in pediatric anesthesia. This prospective double blinded randomized comparative&#xD;
      study is designed to evaluate the analgesic effect of caudal increasing doses of DEXM 0.5 , 1&#xD;
      , 1.5 , 2µg/kg combined with Levobupivacaine (Levob) 0.125% (ED95% =125%=least effective&#xD;
      concentration) in providing pain relief over a 24-h period and lowest surgical stress peak.&#xD;
      Study hypothesis: Levobupivacaine 0.125 %( ED95) combined with different increasing doses of&#xD;
      dexamedatomedine &gt;1 µg/kg could not add more analgesic &amp; stress response obtundation outcome,&#xD;
      but increase side effects (sedation and hemodynamic depression). The peak cortisol level&#xD;
      during urology surgery was at the end of the 1st postoperative (PO) hour. Aim of the Study:&#xD;
      To detect the optimal analgesic and safe caudal adjuvant DEXM dose associated with the least&#xD;
      side effects&amp; stress response modulation, guided by PO Cortisol peak difference in between&#xD;
      the study groups during pediatric hypospadias surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has&#xD;
      been used increasingly in pediatric anesthesia. This prospective double blinded randomized&#xD;
      comparative study is designed to evaluate the analgesic effect of caudal increasing doses of&#xD;
      DEXM 0.5 , 1 , 1.5 , 2µg/kg combined with Levobupivacaine (Levob) 0.125% (ED95% =125%=least&#xD;
      effective concentration) in providing pain relief over a 24-h period and lowest surgical&#xD;
      stress peak. Study hypothesis: Levobupivacaine 0.125 %( ED95) combined with different&#xD;
      increasing doses of dexamedatomedine &gt;1 µg/kg could not add more analgesic &amp; stress response&#xD;
      obtundation outcome, but increase side effects (sedation and hemodynamic depression).The peak&#xD;
      cortisol level during urology surgery was at the end of the 1st postoperative (PO) hour. Aim&#xD;
      of the Study: To detect the optimal analgesic and safe caudal adjuvant DEXM dose associated&#xD;
      with the least side effects&amp; stress response modulation, guided by PO Cortisol peak&#xD;
      difference in between the study groups during pediatric hypospadias surgery.&#xD;
&#xD;
      Optimal effective dose defined as; the least caudal DEXM dose which produce the best&#xD;
      analgesic outcome [least time to 1st analgesic request and lowest rescue analgesic dose&#xD;
      (24Hs)] associated with the least stress response (cortisol PO. first One hour peak), least&#xD;
      PO sedation, and hemodynamic stability IO. &amp;PO. HR &amp; MAP. The peak cortisol level during&#xD;
      urology surgery was at the end of the 1st postoperative (PO) hour.&#xD;
&#xD;
      . Material &amp; Methods A prospective randomized double blinded (drug injector and PO assessor)&#xD;
      comparative study will be conducted in Mansoura university hospital after obtaining ethics&#xD;
      committee approval and written informed parental consent 164 boys (age 1-6 years, ASA I)&#xD;
      scheduled for hypospadias surgery. Exclusion criteria; (Operative time exceeding 3 hours,&#xD;
      bodyweight &gt;25kg, bleeding diathesis, infection at the site of block, pre-existing&#xD;
      neurological or spinal disease or abnormalities of the sacrum, inability to palpate the&#xD;
      sacral hiatus by anatomic landmark palpation technique) or those with a history of allergic&#xD;
      reactions to local anesthetics were excluded from the study. Patients will fast for solids 6h&#xD;
      and water and 2 hours before surgery. After Patient Preoperative preparation, General&#xD;
      anesthesia induction, caudal block and caudal drug injection (Levob plus DEXM) bolus will be&#xD;
      injected according to each group as follow;&#xD;
&#xD;
        -  Group A will take Caudal Levob 0. 125%+ DEXM 0.5µg/kg.&#xD;
&#xD;
        -  Group B will take Caudal Levob 0.125%+ DEXM 1µg/kg.&#xD;
&#xD;
        -  Group C will take Caudal Levob 0. 125%+ DEXM 1.5 µg/kg.&#xD;
&#xD;
        -  Group D will take Caudal Levob 0. 125%+ DEXM 2µg/kg.&#xD;
&#xD;
      The study outcomes recording:&#xD;
&#xD;
      1ry outcome: Time to (1st analgesic request OPS &gt;4). Secondary outcome: Total 24hours PO.&#xD;
      Rescue analgesic dose IM pethidine 0.5mg/kg [2,3] based on local policy and protocol,&#xD;
      Patients demographic data [age, weight, end tidal Sevoflurane (volume %) prior starting skin&#xD;
      closure, intraoperative fentanyl total dose, recovery time (time from discontinuation of&#xD;
      anesthesia to spontaneous eye opening)], Serum Cortisol level at basal before anesthesia and&#xD;
      1hour postoperative in between groups [1] , Apnea incidence (NO&amp;%), and desaturation (NO&amp;%),&#xD;
      Objective pain score, Sedation score, Behavioral score for Agitation assessment, and Modified&#xD;
      bromage score (residual Lower limb muscle weakness) recorded every 15 minutes for 1st hour&#xD;
      then every 30 minutes for next 3 PO hours then at next 6th, 12th, 18th, 24th PO hours,&#xD;
      hemodynamics, HR&amp;SBP the incidence of bradycardia and hypotension per 50% percentile.&#xD;
      Recorded every 10 minutes IO for maximum operative time 3 hours and every 30 min PO for next&#xD;
      2h in the recovery room until the child was discharged to the ward.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">October 15, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to (1st analgesic request objective pain score (OPS) ≥4)</measure>
    <time_frame>Basal (0) till 24 hours.</time_frame>
    <description>time from full recovery till child express moderate pain OPS 4 and ask for the first analgesic dose</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">164</enrollment>
  <condition>164 Boys for Hypospadias Surgery Under General Anesthesia With Caudal Block</condition>
  <arm_group>
    <arm_group_label>• Group A will take Caudal Levob 0. 125%+ DEXM 0.5µg/k</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>• Group B will take Caudal Levob 0.125%+ DEXM 1µg/kg.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>• Group C will take Caudal Levob 0. 125%+ DEXM 1.5 µg/</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>• Group D will take Caudal Levob 0. 125%+ DEXM 2µg/kg.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal dexamedatomidine analgesia</intervention_name>
    <description>Technique performance (Caudal block): classical technique; palpation, identification and puncture with the patients in the lateral position (permits easy access to the airway under general anesthesia) using a 22-G short-beveled needle under sterile conditions advancing needle pierces the sacrococcygeal ligament.&#xD;
After needle insertion, pre-calculated volume of Levob plus DEXM bolus was injected as follow; Group A Caudal Levob 0.125%+ DEXM 0.5µg/kg. Group B Caudal Levob 0.125%+ DEXM 1µg/kg. Group C Caudal Levob 0.125%+ DEXM 1. 5 µg/kg. Group D Caudal Levob 0.125%+ DEXM 2µg/kg.</description>
    <arm_group_label>• Group A will take Caudal Levob 0. 125%+ DEXM 0.5µg/k</arm_group_label>
    <arm_group_label>• Group B will take Caudal Levob 0.125%+ DEXM 1µg/kg.</arm_group_label>
    <arm_group_label>• Group C will take Caudal Levob 0. 125%+ DEXM 1.5 µg/</arm_group_label>
    <arm_group_label>• Group D will take Caudal Levob 0. 125%+ DEXM 2µg/kg.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  164 boys (age 1-8 years, ASA I) scheduled for hypospadias surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Operative time exceeding 3 hours, bodyweight &gt;25kg, bleeding diathesis, infection at&#xD;
             the site of block, pre-existing neurological or spinal disease or abnormalities of the&#xD;
             sacrum, inability to palpate the sacral hiatus by anatomic landmark palpation&#xD;
             technique) or those with a history of allergic reactions to local anesthetics were&#xD;
             excluded from the study&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mohamed A Ghanem, A professor</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura Univeristy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anesthesia department,Faculty of medicine, Mansoura univerisety</name>
      <address>
        <city>Mansoura</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>December 29, 2018</study_first_submitted>
  <study_first_submitted_qc>December 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2019</study_first_posted>
  <last_update_submitted>February 26, 2021</last_update_submitted>
  <last_update_submitted_qc>February 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Abd Latif Ghanim</investigator_full_name>
    <investigator_title>Associate Professor os anesthesia ICU &amp; Pain medicine.</investigator_title>
  </responsible_party>
  <keyword>Caudal</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Levobupivacaine</keyword>
  <keyword>hypospadias</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypospadias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

